Table 2.
Time | Group F | Group R | Group C | P value | |
---|---|---|---|---|---|
At recovery | Nausea (n, %) | 6 (18.8% ) | 10 (31.3%) | 11 (34.4%) | 0.16 |
Vomiting (n, %) | 1 (3.1%) | 2 (6.3%) | 1 (3.1%) | 0.38 | |
VAS (for nausea) | 1.07±0.5 | 1.5±0.8 | 2.2±1.2 | 0.265 | |
VAS (for pain) | 7.62±2.6 | 8.59±2.3 | 7.06±3.08 | 0.078 | |
4 h after surgery | Nausea (n, %) | 2 (6.3%) | 1 (3.1%) | 1 (3.1%) | 0.38 |
Vomiting (n, %) | 0 | 0 | 0 | ||
VAS(for nausea) | 0.88±0.02 | 0.53±0.01 | 0.35±0.01 | 0.832 | |
VAS(for pain) | 6.71±2 | 7.15±2.2 | 6.15±2.4 | 0.206 | |
8 h after surgery | Nausea (n, %) | 0 | 0 | 2(6.3%) | 0.06 |
Vomiting (n, %) | 0 | 0 | 0 | ||
VAS(for nausea) | 0 | 0 | 0.49 | 0.132 | |
VAS(for pain) | 5.78±2.21 | 5.43±2.28 | 5.68±2.44 | 0.828 | |
12 h after surgery | Nausea (n, %) | 0 | 0 | 1 (3.1%) | 0.18 |
Vomiting (n, %) | 0 | 0 | 0 | ||
VAS (for nausea) | 0 | 0 | 0.17 | 0.372 | |
VAS (for pain) | 4.53±2.39 | 4.5±2.52 | 4.12±2.04 | 0.741 | |
24 h after surgery | Nausea (n, %) | 0 | 0 | 1 (3.1%) | 0.18 |
Vomiting (n, %) | 0 | 0 | 0 | ||
VAS (for nausea) | 0 | 0 | 0.17 | 0.382 | |
VAS (for pain) | 2.87±1.64 | 2.75±1.66 | 2.56±1.84 | 0.766 | |
Meperidine used (mg) | 101.2±2 9.5* | 138.1±43.7 | 121.8±35.9* | 0.001 |
VAS: visual analogue scale. *denotes significant difference from remifentanil-treated group